ArticlePharmacy (Basel, Switzerland)2025
Mining of Adverse Event Signals Associated with Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy: A Post-Marketing Analysis Based on FAERS.
Jiajun Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.